Publicaciones (156) Publicaciones de LUIS IGNACIO GONZÁLEZ GRANADO

2024

  1. Enrichment of Immune Dysregulation Disorders in Adult Patients with Human Inborn Errors of Immunity

    Journal of Clinical Immunology, Vol. 44, Núm. 3

  2. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

    The Journal of experimental medicine, Vol. 221, Núm. 2

  3. JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study

    Journal of Allergy and Clinical Immunology, Vol. 153, Núm. 1, pp. 275-286.e18

  4. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells

    Science Immunology, Vol. 9, Núm. 91

  5. The lack of either IRF9, or STAT2, has surprisingly little effect on human natural killer cell development and function

    Immunology

2023

  1. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity

    Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 4, pp. 984-996.e10

  2. Clinical Non-penetrance Associated with Biallelic Mutations in the RNase H2 Complex

    Journal of Clinical Immunology

  3. Dominant-negative heterozygous mutations in AIRE confer diverse autoimmune phenotypes

    iScience, Vol. 26, Núm. 6

  4. Editorial: Primary immune regulatory disorders: Coming of age

    Frontiers in Pediatrics

  5. Inborn Error of STAT2-Dependent IFN-I Immunity in a Patient Presented with Hemophagocytic Lymphohistiocytosis and Multisystem Inflammatory Syndrome in Children

    Journal of Clinical Immunology, Vol. 43, Núm. 6, pp. 1278-1288

  6. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome

    Journal of Allergy and Clinical Immunology, Vol. 151, Núm. 4, pp. 1081-1095

  7. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

  8. Revisiting autoimmune lymphoproliferative syndrome caused by Fas ligand mutations

    Journal of Allergy and Clinical Immunology, Vol. 151, Núm. 5, pp. 1391-1401.e7

  9. Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo

    Molecular Therapy - Methods and Clinical Development, Vol. 30, pp. 546-557

  10. TCF3 haploinsufficiency defined by immune, clinical, gene-dosage, and murine studies

    Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 3, pp. 736-747

  11. Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of CD4+ T-cells for the treatment of Hyper IgM1

    EMBO Journal, Vol. 42, Núm. 23

2022

  1. A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

    Journal of Clinical Immunology, Vol. 42, Núm. 3, pp. 500-511

  2. Altered CXCR4 dynamics at the cell membrane impairs directed cell migration in WHIM syndrome patients

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 21

  3. Autoantibodies against type I IFNs in patients with critical influenza pneumonia

    The Journal of experimental medicine, Vol. 219, Núm. 11

  4. Case report: Novel treatment regimen for enterovirus encephalitis in SCID

    Frontiers in Immunology, Vol. 13